Ozzy Osbourne, rock's wildest frontman, is preparing for his final performance after surviving decades of personal challenges ...

A common cough medicine may slow cognitive decline in people with Parkinson’s disease dementia, a clinical trial has revealed ...

Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...

In 2024, Reynolds joined Acadia Pharmaceuticals for the More to Parkinson’s campaign, which raised awareness about ...

A research team at the Universitat Oberta de Catalunya, working with the Hospital Sant Pau in Barcelona, has shown that ...

Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

A research team at the Universitat Oberta de Catalunya (UOC), working with the Hospital Sant Pau in Barcelona, has shown that ...

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a ...

Okemos, Mich. (WILX) - Kirk Gibson recently turned 68, and for the past 10 years he has battled the effects of Parkinson’s ...

Inhibition of LKKR2 may rescue neurons that are dying due to a type of Parkinson’s disease that is caused by a single genetic ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.